The novel missense mutation Met48Lys in FKBP22 changes its structure and functions

Area of Science:

• Genetics and Molecular Biology
• Connective Tissue Disorders
• Biochemistry

Background:

• Mutations in the FKBP14 gene lead to kyphoscoliotic Ehlers-Danlos Syndrome (kEDS).
• FKBP14 encodes FKBP22 (FK506 Binding Protein 22 kDa), a protein crucial for collagen processing.
• Previous studies linked FKBP22 deficiency to kEDS phenotypes, including kyphoscoliosis and aortic rupture.

Purpose of the Study:

• To identify novel substrates of FKBP22.
• To investigate the functional impact of a newly identified FKBP22 missense mutation (Met48Lys) in kEDS.
• To elucidate the role of FKBP22 in collagen folding and its implications for kEDS pathogenesis.

Main Methods:

• Analysis of FKBP14 gene mutations and their effect on FKBP22 protein.
• Biochemical assays to determine FKBP22's substrate binding profile.
• Prolyl isomerase and molecular chaperone activity assays for wild-type and mutant FKBP22.

Main Results:

• FKBP22 preferentially binds to collagens type III, VI, and X.
• The Met48Lys mutation in FKBP22 significantly reduces its enzymatic and chaperone activities.
• Pathological phenotypes in kEDS can result from complete absence or partial loss of FKBP22 function.

Conclusions:

• FKBP22 plays a vital role in the proper folding and function of specific collagen types.
• Impaired FKBP22 activity due to mutations contributes to the development of kyphoscoliotic Ehlers-Danlos Syndrome.
• Understanding FKBP22's substrate interactions and functional domains is key to developing therapeutic strategies for kEDS.